Observational studyEuropean journal of gastroenterology & hepatology2017

Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results.

Federico Argüelles-Arias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.